Literature DB >> 3088041

Localization of the binding site of tissue-type plasminogen activator to fibrin.

A Ichinose, K Takio, K Fujikawa.   

Abstract

Functionally active A and B chains were separated from a two-chain form of recombinant tissue-type plasminogen activator after mild reduction and alkylation. The A chain was found to be responsible for the binding to lysine-Sepharose or fibrin and the B chain contained the catalytic activity of tissue-type plasminogen activator. An extensive reduction of two-chain tissue-type plasminogen activator, however, destroyed both the binding and catalytic activities. A thermolytic fragment, Fr. 1, of tissue-type plasminogen activator that contained a growth factor and two kringle segments retained its lysine binding activity. Additional thermolytic cleavages in the kringle-2 segment of Fr. 1 caused a total loss of the binding activity. These results indicated that the binding site of tissue-type plasminogen activator to fibrin was located in the kringle-2 segment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088041      PMCID: PMC329545          DOI: 10.1172/JCI112546

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin.

Authors:  K C Robbins; L Summaria; B Hsieh; R J Shah
Journal:  J Biol Chem       Date:  1967-05-25       Impact factor: 5.157

2.  Differences in the binding to fibrin of urokinase and tissue plasminogen activator.

Authors:  S Thorsen; P Glas-Greenwalt; T Astrup
Journal:  Thromb Diath Haemorrh       Date:  1972-08-31

3.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

4.  Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin.

Authors:  S Kasai; H Arimura; M Nishida; T Suyama
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

5.  The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen.

Authors:  B Wiman; P Wallén
Journal:  Thromb Res       Date:  1977-02       Impact factor: 3.944

6.  Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties.

Authors:  P G Lerch; E E Rickli; W Lergier; D Gillessen
Journal:  Eur J Biochem       Date:  1980

7.  Fibrinolytic states in a patient with congenital deficiency of alpha 2-plasmin inhibitor.

Authors:  N Aoki; Y Sakata; M Matsuda; K Tateno
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

8.  A new method of isolation and some properties of the heavy chain of human plasmin.

Authors:  E E Rickli; W I Otavsky
Journal:  Eur J Biochem       Date:  1975-11-15

9.  Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids.

Authors:  S Thorsen
Journal:  Biochim Biophys Acta       Date:  1975-05-30

10.  Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.

Authors:  N Aoki; M Moroi; K Tachiya
Journal:  Thromb Haemost       Date:  1978-02-28       Impact factor: 5.249

View more
  16 in total

Review 1.  Pathophysiology and prevention of postoperative peritoneal adhesions.

Authors:  Willy Arung; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

Review 2.  Postoperative Abdominal Adhesions: Clinical Significance and Advances in Prevention and Management.

Authors:  Demetrios Moris; Jeffery Chakedis; Amir A Rahnemai-Azar; Ana Wilson; Mairead Marion Hennessy; Antonios Athanasiou; Eliza W Beal; Chrysoula Argyrou; Evangelos Felekouras; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-06       Impact factor: 3.452

3.  Kinetic studies on the effect of heparin and fibrin on plasminogen activators.

Authors:  R Fears
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

Review 4.  Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.

Authors:  R Fears
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

5.  Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush.

Authors:  L B Siconolfi; N W Seeds
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

6.  Prediction of the secondary structures of bovine blood coagulation factor IX, factor X, and prothrombin.

Authors:  J M Beals; J Weber; P Derwent; K L Grant; F J Castellino
Journal:  J Protein Chem       Date:  1988-10

7.  The genetic relationships between the kringle domains of human plasminogen, prothrombin, tissue plasminogen activator, urokinase, and coagulation factor XII.

Authors:  F J Castellino; J M Beals
Journal:  J Mol Evol       Date:  1987       Impact factor: 2.395

8.  Binding of tissue plasminogen activator to cultured human endothelial cells.

Authors:  K A Hajjar; N M Hamel; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

9.  Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.

Authors:  X F Cheng; O Bäck; T K Nilsson; E Nylander Lundqvist; G Pohl; P Wallén
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

10.  Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.

Authors:  S Urano; A R Metzger; F J Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.